R. Jayachandra Babu

Citata da

	Tutte	Dal 2019
Citazioni	4048	2357
Indice H	35	23
i10-index	83	60

620

310

155

465

20042005200620072008200920102011201220132014201520162017201820192020202120222023202420 26 44 59 62 83 122 111 133 140 139 152 172 196 189 234 318 451 532 603 214

Accesso pubblico

Visualizza tutto

18 articoli

3 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Amit K. TiwariProfessor and Associate Dean, University of Arkansas for Medical Sciences (UAMS)Email verificata su uams.edu
Mandip Singh SachdevaProfessor, FAMU College of PharmacyEmail verificata su famu.edu
Manjusha AnnajiFood and Drug AdministrationEmail verificata su fda.hhs.gov
Sai Hanuman Sagar BodduProfessor of Pharmaceutics, Ajman UniversityEmail verificata su ajman.ac.ae
Robert D Arnold "Rusty"Professor and Director of Research, Auburn UniversityEmail verificata su auburn.edu
Ranjeet DashSenior Scientist, The Janssen Pharmaceutical Companies of Johnson & JohnsonEmail verificata su its.jnj.com
sateesh kumar sathigariPatheon PharmaceuticalsEmail verificata su Patheon.com
Muralikrishnan DhanasekaranAuburn UniversityEmail verificata su auburn.edu
Rabin NeupaneUniversity of ToledoEmail verificata su rockets.utoledo.edu
Vijay RangariTuskegee UniversityEmail verificata su tuskegee.edu
Kasturi Pawar, PhDAuburn UniversityEmail verificata su auburn.edu
Gurkishan Singh ChadhaUniversity of New England, MaineEmail verificata su une.edu
Forrest SmithProfessor or Drug Discovery and Development, Auburn UniversityEmail verificata su auburn.edu
Srinath PalakurthiTexas A&M Health Science Center College of PharmacyEmail verificata su tamhsc.edu
Dr. Rishi PaliwalAssociate Professor, Indira Gandhi National Tribal University, Amarkantak, MP, IndiaEmail verificata su igntu.ac.in
Temesgen SamuelTuskegee UniversityEmail verificata su tuskegee.edu
Ram B GuptaAssociate Dean for Research, Professor, Virginia Commonwealth UniversityEmail verificata su vcu.edu
Ganesh SanganwarPrincipal Engineer, Solvay USAEmail verificata su solvay.com
Virginia A. DavisAuburn UniversityEmail verificata su auburn.edu
Vinod RadhakrishnanAuburn UniversityEmail verificata su tigermail.auburn.edu

Segui

R. Jayachandra Babu

Altri nomiRamapuram Jayachandra Babu, Jayachandra Babu Ramapuram, Jay Ramapuram

Auburn University, Harrison Collge of Pharmacy

Email verificata su auburn.edu

transdermal solubility cyclodextrins 3D printing nanoparticles


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Nanomedicine scale-up technologies: feasibilities and challenges R Paliwal, RJ Babu, S Palakurthi Aaps Pharmscitech 15 (6), 1527-1534, 2014	310	2014
Alternatives to biological skin in permeation studies: Current trends and possibilities R Neupane, SHS Boddu, J Renukuntla, RJ Babu, AK Tiwari Pharmaceutics 12 (2), 152, 2020	221	2020
Amorphous-state characterization of efavirenz—polymer hot-melt extrusion systems for dissolution enhancement SK Sathigari, VK Radhakrishnan, VA Davis, DL Parsons, RJ Babu Journal of pharmaceutical sciences 101 (9), 3456-3464, 2012	161	2012
Role of cyclodextrins in nanoparticle-based drug delivery systems H Shelley, RJ Babu Journal of pharmaceutical sciences 107 (7), 1741-1753, 2018	151	2018
Physicochemical characterization of efavirenz–cyclodextrin inclusion complexes S Sathigari, G Chadha, YHP Lee, N Wright, DL Parsons, VK Rangari, ... Aaps Pharmscitech 10, 81-87, 2009	120	2009
In vitro and in vivo evaluation of topical formulations of spantide II L Kikwai, RJ Babu, R Prado, A Kolot, CA Armstrong, JC Ansel, M Singh Aaps Pharmscitech 6, E565-E572, 2005	114	2005
Formulation of controlled release gellan gum macro beads of amoxicillin RJ Babu, S Sathigari, MT Kumar, JK Pandit Current drug delivery 7 (1), 36-43, 2010	111	2010
Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems RJ Babu, JK Pandit International journal of pharmaceutics 288 (2), 325-334, 2005	94	2005
Formulation and in vitro evaluation of transdermal patches of melatonin N Kanikkannan, S Andega, S Burton, RJ Babu, M Singh Drug development and industrial pharmacy 30 (2), 205-212, 2004	91	2004
Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin RJ Babu, JK Pandit International journal of pharmaceutics 271 (1-2), 155-165, 2004	90	2004
Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size … P Dayal, V Pillay, RJ Babu, M Singh Aaps Pharmscitech 6, E573-E585, 2005	85	2005
Resveratrol‐loaded nanomedicines for cancer applications M Annaji, I Poudel, SHS Boddu, RD Arnold, AK Tiwari, RJ Babu Cancer reports 4 (3), e1353, 2021	82	2021
Biomaterial-derived calcium carbonate nanoparticles for enteric drug delivery D Render, T Samuel, H King, M Vig, S Jeelani, RJ Babu, V Rangari Journal of nanomaterials 2016, 2016	77	2016
Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: an insight from the published in vitro, preclinical and clinical studies RP Dash, R Jayachandra Babu, NR Srinivas European journal of drug metabolism and pharmacokinetics 42, 915-933, 2017	74	2017
Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro L Kikwai, N Kanikkannan, RJ Babu, M Singh Journal of controlled release 83 (2), 307-311, 2002	73	2002
Lipid materials for topical and transdermal delivery of nanoemulsions KR Pawar, RJ Babu Critical Reviews™ in Therapeutic Drug Carrier Systems 31 (5), 2014	71	2014
Two decades-long journey from riluzole to edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics RP Dash, RJ Babu, NR Srinivas Clinical pharmacokinetics 57, 1385-1398, 2018	62	2018
Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin RJ Babu, JK Pandit Drug Delivery 12 (3), 165-169, 2005	60	2005
The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide RJ Babu, N Kanikkannan, L Kikwai, C Ortega, S Andega, K Ball, S Yim, ... Journal of controlled release 86 (1), 49-57, 2003	58	2003
Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 … RP Dash, RJ Babu, NR Srinivas Xenobiotica 48 (1), 89-108, 2018	53	2018

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori